The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury
RebelEM
FEBRUARY 29, 2024
11 Curiously, VAP in patients with traumatic head injury does not appear to increase mortality, but does increase ventilator time, ICU, and hospital length of stay. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. El-Ebiary, M.; Fábregas, N.; Hernández, C.;
122 
Let's personalize your content